CFR should top the .007 Mark as Market overseas rises , Diamonds in hand and sure to be plenty more come on Cluff.(Nothing but up
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%